Fiera Capital Corp Invitae Corp Transaction History

Fiera Capital Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$7.64 - $27.5 $778,943 - $2.8 Million	-101,956 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$15.02 - $20.57 $36,738 - $50,314	-2,446 Reduced 2.34%	101,956 $1.64 Million
Q3 2019 Nov 12, 2019	SELL	$18.85 - $27.5 $266,539 - $388,850	-14,140 Reduced 11.93%	104,402 $2.01 Million
Q2 2019 Aug 12, 2019	SELL	$17.37 - $26.27 $99,790 - $150,921	-5,745 Reduced 4.62%	118,542 $2.79 Million
Q1 2019 May 10, 2019	SELL	$10.65 - $25.75 $579,391 - $1.4 Million	-54,403 Reduced 30.45%	124,287 $2.91 Million
Q4 2018 Feb 12, 2019	BUY	$9.26 - $16.38 $1.65 Million - $2.93 Million	178,690 New	178,690 $1.98 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.